News Search Results
May 08, 2025, 11:20 ET Home Healthcare Market Poised to Reach $ 747.70 Billion by 2030 at CAGR 10.21% - Grand View Research, Inc.
Home Healthcare Market The demand for home care services is expected to increase in the immediate future, owing to the ongoing COVID-19 pandemic. These services are safer and cost-effective alternatives to hospital services. External substitutes, including hospitals, informal care,
More news about: Grand View Research, Inc.
May 08, 2025, 10:58 ET DNV recognized as a Notified Body for Certification under In Vitro Diagnostic Regulation (IVDR)
diagnostics (IVDs) are tests used to determine a person's health status. They range from pregnancy and cholesterol tests through to HIV screening, COVID-19 tests and cancer marker detection. The safety and effectiveness of such devices is therefore crucial to public and personal health. The EU
More news about: DNV
May 08, 2025, 10:33 ET DNV recognized as a Notified Body for Certification under In Vitro Diagnostic Regulation (IVDR)
diagnostics (IVDs) are tests used to determine a person's health status. They range from pregnancy and cholesterol tests through to HIV screening, COVID-19 tests and cancer marker detection. The safety and effectiveness of such devices is therefore crucial to public and personal health. The EU
More news about: DNV
May 08, 2025, 08:30 ET BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
Europe. During the COVID-19 pandemic, Junshi Biosciences actively shouldered the social responsibilities of a Chinese pharmaceutical company through its involvement in developing etesevimab, MINDEWEI®, and other novel therapies for the prevention and treatment of COVID-19. With a mission of
More news about: BioDlink Biopharm Co., Ltd.
May 08, 2025, 08:24 ET Tire Bank Group Acquires Controlling Stake in Air Premia
a pivotal role in supporting the airline's development through strategic investments. Despite global headwinds and the unprecedented impact of the COVID-19 pandemic, Air Premia has demonstrated remarkable operational resilience and adaptability. Tire Bank Group maintained unwavering confidence
More news about: Air Premia
May 08, 2025, 08:05 ET TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported
similar uses; risks associated with TransCode's dependence on third parties; and risks associated with geopolitical events and pandemics, including the COVID-19 coronavirus and military actions. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause
More news about: TransCode Therapeutics, Inc.
May 08, 2025, 08:00 ET Novavax Reports First Quarter 2025 Financial Results and Operational Highlights
delays in obtaining regulatory authorization or approval for its COVID-19 vaccine, in particular with respect to its BLA submission to the FDA for approval of its COVID-19 vaccine, or its other product candidates, including for future COVID-19 variant strain changes, its CIC vaccine candidate, its stand-alone
More news about: Novavax, Inc.
May 08, 2025, 08:00 ET O CURECA(TM) da Seegene surge como um potencial divisor de águas na automação de ponta a ponta da PCR
tecnologias de PCR sindrômico em tempo real. Essa experiência foi particularmente importante durante a pandemia da COVID-19, quando a Seegene forneceu mais de 340 milhões de testes de COVID-19 para mais de 100 países em todo o mundo. A característica central da tecnologia de PCR em tempo real sindrômica
More news about: Seegene Inc.
May 08, 2025, 08:00 ET NaaS Recognized with 2025 Sustainable Consumer Engagement Award, the Sole Recipient in EV Charging Service Sector
NaaS' ability to protect and enforce its intellectual property rights; NaaS' ability to attract and retain qualified executives and personnel; the COVID-19 pandemic and the effects of government and other measures that have been or will be taken in connection therewith; U.S.-China
More news about: NaaS Technology Inc.
May 08, 2025, 06:59 ET Cogent Communications Reports First Quarter Results and Increases its Regular Quarterly Dividend on its Common Stock
Wireline Business and the related costs continuing for a longer period than expected; transition related costs associated with the acquisition; the COVID-19 pandemic and the related government policies; future economic instability in the global economy, including the risk of economic recession, recent
More news about: Cogent Communications Holdings, Inc.
May 08, 2025, 04:00 ET O CURECATMda Seegene surge como potencial mudança de paradigma na automação integral de PCR
tecnologias de PCR sindrómicas em tempo real. Esta experiência destacou-se, em particular, durante a pandemia de COVID-19, quando a Seegene forneceu mais de 340 milhões de testes COVID-19 a mais de 100 países em todo o mundo. A caraterística principal da tecnologia de PCR sindrómica da Seegene é a capacidade
More news about: Seegene Inc.
May 08, 2025, 03:00 ET CURECA(TM) firmy Seegene może stać się przełomem w kompleksowej automatyzacji PCR
technologii real-time PCR do diagnostyki syndromicznej. To doświadczenie przydało się szczególnie podczas pandemii COVID-19, gdy Seegene dostarczył ponad 340 milionów testów na COVID-19 do przeszło 100 krajów na całym świecie. Technologia real-time PCR do diagnostyki syndromicznej, którą opracowała firma
More news about: Seegene Inc.
May 08, 2025, 03:00 ET CURECA™ di Seegene si prospetta come un potenziale punto di svolta nell'automazione completa della PCR
alle tecnologie real-time PCR sindromiche. Questa competenza è apparsa particolarmente evidente durante la pandemia di COVID-19, quando Seegene ha fornito oltre 340 milioni di test COVID-19 in più di 100 paesi in tutto il mondo. La tecnologia PCR sindromica di Seegene consente la rilevazione simultanea di
More news about: Seegene Inc.
May 08, 2025, 03:00 ET CURECA(TM) de Seegene tiene el potencial de transformar la automatización integral de las pruebas PCR
tecnologías de PCR sindrómica en tiempo real. Esta experiencia se puso especialmente de manifiesto durante la pandemia de COVID-19, cuando Seegene suministró más de 340 millones de pruebas de COVID-19 a más de 100 países de todo el mundo. La característica principal de la tecnología PCR sindrómica en tiempo real
More news about: Seegene Inc.
May 08, 2025, 03:00 ET Systém CURECA(TM) od společnosti Seegene přináší potenciální převrat v kompletní automatizaci PCR
vývojem, výrobou a obchodem v oblasti technologií syndromických PCR v reálném čase. Její odbornost svět pocítil zejména během pandemie onemocnění COVID-19, kdy do více než 100 zemí poskytla více než 340 milionů testů na toto onemocnění. Základním prvkem jedinečné technologie syndromických PCR v reálném
More news about: Seegene Inc.
May 08, 2025, 03:00 ET CURECA™ de Seegene : une évolution décisive dans l'automatisation complète des tests PCR.
dans le domaine des technologies PCR syndromique en temps réel. Ces compétences ont été particulièrement mises en lumière lors de la pandémie de COVID-19, au cours de laquelle Seegene a fourni plus de 340 millions de tests à plus de 100 pays dans le monde. La principale caractéristique de la technologie
More news about: Seegene Inc.
May 08, 2025, 02:00 ET Решение CURECA(TM) компании Seegene способно в корне изменить полную автоматизацию тестирования методом ПЦР
связанного с синдромным подходом к ПЦР-тестированию в реальном времени. Этот опыт был особенно важен во время пандемии COVID-19, когда компания Seegene поставила свыше 340 миллионов тестов на COVID-19 более чем в 100 стран мира. Основной особенностью технологии синдромной диагностики в режиме реального времени
More news about: Seegene Inc.
May 07, 2025, 22:00 ET Seegene CURECA(TM) Berpotensi Menjadi Terobosan Penting yang Mengotomatisasi Alur Kerja PCR secara Terpadu
teknologi PCR seketika (real-time) selama lebih dari 20 tahun. Pengalaman Seegene terbukti ketika pandemi Covid-19 terjadi. Saat itu, Seegene menyediakan lebih dari 340 juta alat tes Covid-19 untuk lebih dari 100 negara di seluruh dunia. Teknologi PCR Seegene mampu memeriksa 14 patogen yang menyebabkan
More news about: Seegene Inc.
May 07, 2025, 21:03 ET Penetrium™ Breaks Oncology Barriers: The Solution to Cold Tumors and Metastatic Cancer Unveiled at AACR 2025
than 9% of the NOAEL dose established in a 13-week GLP-compliant toxicity study. Its safety has also been verified in humans during a Phase 2 COVID-19 trial using the same API, niclosamide. These results confirm Penetrium™ is fully prepared for human clinical application. Official
More news about: Hyundai Bioscience
May 07, 2025, 16:05 ET Hippo Reports First Quarter 2025 Financial Results and will Hold an Investor Day on June 12, 2025
and other natural or man-made catastrophes, including the effects of climate change, global pandemics, and terrorism; continued disruptions from the COVID-19 pandemic; any overall decline in economic activity; regulators' identification of errors in the policy forms we use, the rates we charge, and our
More news about: Hippo Analytics, Inc
May 07, 2025, 16:05 ET Universal Technical Institute Reports Fiscal Year 2025 Second Quarter Results
the potential in the future to gain substantial control over our company; the effect of public health pandemics, epidemics or outbreak, including COVID-19, and other risks that are described from time to time in our public filings. Further information on these and other potential factors that could affect
More news about: Universal Technical Institute, Inc.
May 07, 2025, 13:54 ET Virtual Desktop Infrastructure (VDI) Software Market to Reach USD 62,175.53 Million By 2032, Growing At An 18.53% CAGR - Credence Research
increasingly deploying VDI solutions to provide secure, flexible access to corporate systems for remote employees. This trend was accelerated by the COVID-19 pandemic and continues to shape IT infrastructure decisions, prompting long-term investments in virtual desktop environments. Rising Focus
More news about: Credence Research Inc.
May 07, 2025, 10:43 ET Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy
October 2017 and June 2022. Researchers note that some therapy and assessments occurred during the COVID-19 pandemic, but improvements were sustained despite how the pandemic may have impacted participants' lives unfavorably. Sex, age, side of stroke, and
More news about: MicroTransponder Inc.
May 07, 2025, 10:09 ET Corticosteroid API Market Poised for a 6% CAGR Growth Through 2031: What You Need to Know | Valuates Reports
APIs are integral in treating conditions such as asthma, rheumatoid arthritis, severe allergies, and certain types of cancers. Their inclusion in COVID-19 treatment protocols has further elevated their importance and demand. Due to their potency, even low doses provide effective outcomes, making them
More news about: Valuates Reports
May 07, 2025, 10:05 ET In Vitro Diagnostics Market Size to be Worth $150.13 Billion by 2030 at CAGR 5.62% - Grand View Research, Inc.
USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy,
More news about: Grand View Research, Inc.